Novel Immunotherapeutics for Treatment of Glioblastoma: The Last Decade of Research-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel Immunotherapeutics for Treatment of Glioblastoma: The Last Decade of Research

Published:2019-01-02 Issue:1 Volume:37 Page:1-7
ISSN:0735-7907
Container-title:Cancer Investigation
language:en
Short-container-title:Cancer Investigation

Author:

Khansur Emaad¹,Shah Ashish H.²,Lacy Kyle³,Komotar Ricardo J.²

Affiliation:

1. School of Medicine, University of Mississippi, Jackson, MS, USA;

2. Department of Neurosurgery, University of Miami/Jackson Memorial Hospital, Miami, FL, USA;

3. Department of Hematology/Oncology, University of Miami/Jackson Memorial Hospital, Miami, FL, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/07357907.2018.1479414

Reference48 articles.

1. The development of dendritic cell vaccine-based immunotherapies for glioblastoma

2. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

3. Survival after Stereotactic Biopsy of Malignant Gliomas

4. Survival analysis of 205 patients with glioblastoma multiforme: Clinical characteristics, treatment and prognosis in China

5. Recent advances and future of immunotherapy for glioblastoma

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glioblastoma Treatment: State-of-the-Art and Future Perspectives;International Journal of Molecular Sciences;2022-06-29

2. PRLHR Immune Genes Associated With Tumor Mutation Burden can be Used as Prognostic Markers in Patients With Gliomas;Frontiers in Oncology;2022-06-21

3. TLR-4 Signaling vs. Immune Checkpoints, miRNAs Molecules, Cancer Stem Cells, and Wingless-Signaling Interplay in Glioblastoma Multiforme—Future Perspectives;International Journal of Molecular Sciences;2020-04-28

4. Identification of immunologic subtype and prognosis of GBM based on TNFSF14 and immune checkpoint gene expression profiling;Aging;2020-04-20

5. Personalized neoantigen vaccines: a glimmer of hope for glioblastoma;Expert Review of Vaccines;2020-04-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3